One hundred patients with newly diagnosed multiple myeloma (MM) were treated with high-dose chemotherapy followed by single or double autologous stem cell transplantation (ASCT). Up-front treatment with a double ASCT tended to prolong progression-free and overall survival.
Figures & Tables
Article Information
Vol. 90 No. 4 (2005): April, 2005 : Letters to the Editor
M Putkonen, A Rauhala, M Itala, M Kauppila, TT Pelliniemi, K Remes. Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patients. Haematologica 2005; 90(4):562-563; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is required.
For information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
